Autoimmune Hepatitis : News
Print
Email
SaveHealthline's Premium Tools
Symptom Search
Discover possible causes based on the symptoms you enter. It's fast, convenient and easy to use.
Discover possible causes based on the symptoms you enter. It's fast, convenient and easy to use.
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
|
... but the numbers are high when you look at how many people drink in excess. The second most common cause is hepatitis C. We have about 4 million people in the Unites States with hepatitis C, and 20 percent of those patients with hepatitis C will ...
|
|
Q: You mentioned Padma Basic in a recent article and how it might help autoimmune conditions.
|
|
... disease affecting approximately one percent of the population. Joint destruction associated with this autoimmune condition results from synovial infiltration by various classes of immune cells which cause inflammation and joint destruction. This ...
|
|
... trials. a. Abbreviations: CpG, cytosine phosphate guanosine; dsRNA, double stranded ribonucleic acid; HCV, hepatitis C virus; IFN, interferon; LPS, lipopolysaccharide; μM, micromolar; MyD88, myeloid differentiation factor 88; nM, nanomolar; ...
|
|
Representative Patrick Kennedy introduced H.R. 7078, known as the Prevention, Awareness, and Research of Autoimmune Diseases Act of 2008, to Congress on September 25, 2008.
|
|
Although most hepatitis B vaccines do not seem to increase the risk of multiple sclerosis in children, use of one particular brand -- Engerix B -- may, according to findings from a study conducted in France.
|
|
... School in 1977 and spent 14 years in the Marine Corps, is on dialysis three days per week. She was diagnosed with autoimmune hepatitis, which is the body's immune system attacking the liver, in 2004. According to researchers, a genetic factor might ...
|
|
... q8h or q12h with Peginterferon-Alfa-2a or -Alfa-2b and Ribavirin in Treatment-NaAve Subjects with Genotype 1 Hepatitis C: Week 4 Interim Results" and the abstract is to be presented at a poster session on Tuesday, November 4 from 8:00 a.m. to 12:30 ...
|
|
Background Certain autoimmune and infectious conditions are associated with increased risks of subtypes of non-Hodgkin lymphoma.
|
|
... factors to date, Koshiol et al found a 2- to 3-fold elevated risk of WM among persons with a personal history of autoimmune diseases with autoantibodies and notably elevated risks for hepatitis, human immunodeficiency virus, and rickettsiosis. These ...
|
|
... Company, a Ukraine-located vaccine manufacturer, to conduct clinical trials of Healive, Sinovac's inactivated hepatitis A vaccine, in the Ukraine (see story ). Biolik, which will market and distribute Healive in the Ukraine after it obtains ...
|
|
... today that it has signed a definitive license agreement with Amgen Inc. to expand its commercial rights to the hepatitis C drug Infergen. Three Rivers Pharmaceuticals will obtain commercial rights to Infergen in all markets except Japan. In ...
|
|
... receptor on their surface, findings that may advance the development of new therapies for diseases such as HIV, hepatitis B and C, and cancer. In their study, published online September 15 in the Proceedings of the National Academy of Sciences ...
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.